Atlas Trials

Interaction Between Reboxetine and 3,4-Methylenedioxymethamphetamine: Pharmacodynamics (PD) and Pharmacokinetics (PK)

Clinical trial NCT00886886 · COMPLETED

Trial details

NCT number
NCT00886886
Sponsor
University Hospital, Basel, Switzerland
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Mood DisorderSubstance-related DisordersAmphetamine-related Disorders
Start date
2009-04-01
Primary completion
2009-12-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.